Skip to main content
Log in

Increased healthcare burden with treatment-resistant depression in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. funded by Janssen Scientific Affairs, LLC

Reference

  • Shrestha A, et al. Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers. Psychiatric Services : appips201900398, 2 Apr 2020. Available from: URL: http://dx.doi.org/10.1176/appi.ps.201900398

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Increased healthcare burden with treatment-resistant depression in the US. PharmacoEcon Outcomes News 851, 25 (2020). https://doi.org/10.1007/s40274-020-6748-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6748-y

Navigation